V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20051991 | 20086518 | 1.5 | 75 | 03 | 2018-04-02 | 2018-04-07 | CTD | 02 | N | ACELARATE TRIAL | 101301229 |
| 20052086 | 20086519 | 1.68 | 69 | 03 | 2019-09-26 | 2019-12-29 | Raltitrexed | 02 | N | SCOPE2 TRIAL | 100799135 |
| 20052128 | 20086521 | 1.61 | 74.2 | 03 | 2019-07-24 | 2019-07-28 | OXALIPLATIN + MDG + PANITUMUMAB | 01 | N | GEMCITABINE + PACLITAXEL | 100831931 |
| 20052151 | 20086522 | 1.78 | 85 | 03 | 2017-07-22 | 2017-08-18 | UKALL 14 TRIAL | 02 | N | CISPLATIN + FLUOROURACIL + MITOMYCIN | 101824533 |
| 20052252 | 20086523 | 1.9 | 76 | Palliative (P) | 2016-09-20 | 2016-10-19 | ECarboF | 01 | N | PLATO TRIAL | 101449590 |
| 20052274 | 20086524 | 1.57 | 76.6 | 03 | 2018-04-23 | 2018-05-24 | IPILIMUMAB + NIVOLUMAB | N | N | IRINOTECAN + MDG + PANITUMUMAB | 100661513 |
| 20052287 | 20086525 | 1.85 | 68.5 | 03 | 2019-12-29 | 2020-01-09 | Rituximab | 02 | N | CISPLATIN + RT | 100052522 |
| 20052313 | 20086527 | 1.54 | 78.4 | null | 2017-02-21 | 2017-02-22 | BCG Intravesical | 02 | N | ABIRATERONE | 100341905 |
| 20052322 | 20086528 | 1.44 | 101 | Palliative (P) | 2016-04-18 | 2016-04-27 | ACTICCA-1 Trial | 02 | N | CARBO + FLUOROURACIL | 100576546 |
| 20052355 | 20086529 | null | 69.8 | null | 2018-04-18 | 2018-05-07 | NEO-AEGIS TRIAL | 02 | null | ACELARATE TRIAL | 100351062 |
| 20052366 | 20086530 | 1.68 | 95.4 | Palliative (P) | 2015-10-09 | 2015-10-09 | CISPLATIN + VINORELBINE | N | N | ARISTOTLE TRIAL | 100234025 |
| 20052437 | 20086531 | 1.48 | 81.6 | 03 | 2019-11-10 | 2019-11-10 | OXALIPLATIN | null | N | BORTEZOMIB + MELPHALAN | 100183512 |
| 20052439 | 20086532 | 1.55 | 56.6 | 03 | 2016-09-13 | 2016-09-13 | NIVOLUMAB | 02 | N | REGORAFENIB | 100409001 |
| 20052444 | 20086533 | null | 12.3 | Adjuvant (A) | null | 2018-12-07 | CAP + RT | N | Y | IPILIMUMAB + NIVOLUMAB | 101279755 |
| 20052445 | 20086534 | 1.57 | 46.3 | 03 | 2016-03-09 | 2016-03-10 | RALTITREXED | 02 | N | EPIRUBICIN | 100920005 |
| 20052461 | 20086535 | null | 81.6 | Palliative (P) | 2016-09-22 | 2016-09-22 | PLATO Trials | 02 | N | PLATO TRIAL | 101535716 |
| 20052475 | 20086536 | 1.63 | 78.6 | Palliative (P) | 2018-09-09 | 2018-09-10 | Capital Trial | 02 | Y | RITUXIMAB | 100834135 |
| 20052484 | 20086537 | 1.64 | 73.3 | Palliative (P) | 2021-07-02 | 2021-07-22 | Bortezomib (weekly) | 02 | N | RITUXIMAB | 101022083 |
| 20052510 | 20086539 | null | null | Palliative (P) | 2017-06-03 | 2017-06-09 | CARBOPLATIN + GEMCITABINE | 02 | N | VENETOCLAX | 101230571 |
| 20052530 | 20086540 | 1.7 | null | Palliative (P) | 2018-08-12 | 2018-08-22 | Ifosfamide PVI 1g/m2 14day | 02 | N | EVEROLIMUS | 100612259 |
| 20052543 | 20086541 | 1.67 | 97.35 | null | null | 2016-07-14 | OXALIPLATIN + MDG + PANITUMUMAB | 01 | N | AML19 TRIAL | 101622873 |
| 20052570 | 20086542 | 1.8 | 51.7 | Neo-adjuvant (N) | 2017-09-26 | 2017-09-26 | Fluorouracil + Folinic + RT Bossett | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101319743 |
| 20052571 | 20086543 | 1.49 | 60.9 | Palliative (P) | 2016-05-16 | 2016-05-19 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | Y | MCX | 101795778 |
| 20052722 | 20086544 | 1.74 | 72.7 | Palliative (P) | 2016-11-19 | 2016-12-03 | FEC 60 or 75 | 02 | N | GEMCITABINE + PACLITAXEL | 100052254 |
| 20052725 | 20086545 | 1.5 | 78.8 | Palliative (P) | 2017-03-19 | 2017-04-08 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CARBO + FLUOROURACIL | 100118782 |
| 20052817 | 20086546 | 1.62 | 62.4 | null | 2019-12-02 | 2019-12-02 | PLATO Trials | 02 | N | PLATO TRIAL | 100372189 |
| 20052826 | 20086547 | null | 63 | 03 | 2017-04-26 | 2017-07-13 | Bortezomib + CYCLOPHOSPHAMIDE | 01 | N | DOCETAXEL | 101193723 |
| 20052884 | 20086548 | 1.77 | 82 | null | 2016-12-07 | 2016-12-23 | GemCarbo Days 1+8 | 02 | N | CAPECITABINE + IRINOTECAN + RT | 100785204 |
| 20052893 | 20086549 | 1.62 | 92.7 | 03 | 2017-06-02 | 2017-06-10 | PEMBROLIZUMAB | 02 | N | BEVACIZUMAB + OXALIPLATIN + MdG | 101692327 |
| 20052919 | 20086550 | 1.75 | 85 | null | 2016-04-29 | 2016-04-29 | PHITT C SIOPEL-3HR | 02 | N | ABVD | 100368074 |
| 20052942 | 20086551 | 1.61 | 105 | Palliative (P) | 2019-01-05 | 2019-01-05 | Everolimus 10mg | 02 | N | HYDROXYCARBAMIDE | 100821022 |
| 20052964 | 20086552 | 1.66 | 67 | null | 2021-07-04 | 2021-07-19 | Raltitrexed | 02 | N | CARBO + FLUOROURACIL | 100295106 |
| 20052966 | 20086553 | 1.62 | 69.8 | Palliative (P) | null | 2017-10-22 | ESPAC TRIAL | 02 | N | RUXOLITINIB | 101593826 |
| 20052967 | 20086554 | 1.58 | 68 | 03 | 2018-03-08 | 2018-03-27 | Cisplatin +FU +Trastuzumab - Load | 02 | N | AZACITIDINE + VENETOCLAX | 100309075 |
| 20052968 | 20086555 | 1.73 | 88.7 | null | 2016-04-12 | 2016-04-15 | NEO-AEGIS TRIAL | 02 | N | PEMBROLIZUMAB | 100886751 |
| 20052976 | 20086556 | 0 | 0 | 03 | 2016-04-04 | 2016-04-23 | Hydroxycarbamide | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101203665 |
| 20053056 | 20086558 | 1.69 | 83.9 | null | 2018-10-21 | 2018-11-24 | NAB PACLITAXEL | 02 | N | OXALIPLATIN | 101457667 |
| 20053064 | 20086559 | 1.59 | 49.2 | 03 | 2018-08-02 | 2018-08-03 | EVEROLIMUS | N | null | BORTEZOMIB + CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB | 100704554 |
| 20053097 | 20086561 | 1.55 | 80.2 | Palliative (P) | null | 2017-05-03 | GO2 TRIAL | 01 | N | ACTICCA-1 TRIAL | 100283424 |
| 20053107 | 20086562 | 0 | 0 | Palliative (P) | 2019-05-14 | 2019-05-15 | CHOP R | 02 | N | REGORAFENIB | 101697801 |
| 20053164 | 20086564 | 1.79 | 58.1 | null | 2018-04-12 | 2018-05-09 | SCOPE 2 TRIAL | 02 | N | NOT MATCHED | 101727017 |
| 20053165 | 20086565 | 1.7 | 85.75 | 03 | 2016-07-24 | 2016-08-01 | CVP R | N | N | NOT MATCHED | 100737560 |
| 20053167 | 20086566 | null | null | Palliative (P) | 2017-12-03 | 2017-12-10 | Cisplatin + Vinorelbine (PO) | 02 | N | ACTICCA-1 TRIAL | 101714256 |
| 20053177 | 20086567 | 1.74 | 52.65 | Palliative (P) | 2019-01-07 | 2019-01-15 | ECarboX | 02 | N | NIVOLUMAB | 101612367 |
| 20053205 | 20086568 | null | null | 03 | 2018-05-06 | 2018-05-06 | EC | 01 | null | ANAGRELIDE | 101806484 |
| 20053208 | 20086569 | 1.78 | 93.5 | Palliative (P) | 2018-11-05 | 2018-11-14 | EVEROLIMUS | 02 | N | EVEROLIMUS | 101288892 |
| 20053221 | 20086570 | 1.75 | 54.6 | Palliative (P) | 2019-08-10 | 2019-08-21 | LENALIDOMIDE | 02 | N | IBRUTINIB | 100170678 |
| 20053270 | 20086572 | 1.56 | 77 | Palliative (P) | 2018-07-25 | 2018-08-07 | Capital Trial | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101270416 |
| 20053291 | 20086573 | 1.58 | 111.7 | Palliative (P) | 2015-02-03 | 2015-02-03 | Sunitinib | 02 | N | ESPAC TRIAL | 101272528 |
| 20053393 | 20086575 | 1.63 | 63.7 | Palliative (P) | 2016-12-09 | 2016-12-09 | MITOMYCIN | 01 | N | ESPAC TRIAL | 101507341 |